News

Navigating Cancer Boosts Innovation with New Care Management Strategies

Navigating Cancer Boosts Innovation with New Care Management Strategies

Navigating Cancer Drives Innovation with New Care Management Strategies

  • The acquisition by OneOncology accelerates innovation in the leading care management platform and patient-reported outcomes tool, with no extra cost to customers.
  • Currently, 2,000 providers and 1 million patients benefit from Navigating Cancer, with further growth expected through the OneOncology partnership.
  • New features will create additional revenue opportunities for practices through value-based care programs and the enablement of novel therapies.

Navigating Cancer, a frontrunner in patient engagement and care management for oncology, has announced its dedication to making significant technology investments that will benefit healthcare providers, clinic staff, and patients alike. This transformation is made possible by its recent acquisition by OneOncology, the fastest-growing platform focused on independent oncology practices.

Significance of the OneOncology Acquisition

The acquisition by OneOncology marks the beginning of a new phase of substantial product investment in Navigating Cancer's fully oncology-focused patient portal and care management solutions. Importantly, Navigating Cancer will continue to operate independently, maintaining its commitment to community oncology practices, regardless of their management affiliations.

Fostering Innovation in Patient Care

Dr. Jeff Patton, CEO of OneOncology, stated, "Healthcare unfortunately lags behind other industries in technology adoption, so we are choosing to be innovators and leaders in advancing technology solutions that benefit all community oncology practices." This statement underscores a commitment to enhancing patient engagement, ensuring adherence to medication protocols, and improving workflow efficiencies for healthcare providers.

New Features in Development

With the support of OneOncology's extensive clinical expertise, Navigating Cancer is poised to innovate and roll out new product features that will enhance every patient interaction. This will create a more seamless experience for both physicians and their patients. Upcoming enhancements include support for bi-specific therapies, improved medication adherence functionality, expanded Chronic Care Management features, and better integration with the most commonly used Electronic Medical Records (EMR) systems.

Proven Advantages of Navigating Cancer's Platform

There is a wealth of research demonstrating the benefits of using Navigating Cancer’s care management platform. Recent studies show that remote monitoring of patient symptoms through electronic patient-reported outcomes (e-PROs) can lead to significant reductions in hospitalization rates—specifically, a 39 percent decrease—and a 33 percent reduction in adverse events. This translates to an average savings of $1,146 per patient in large oncology settings.

Enhancing Operations for Improved Outcomes

Bill Bunker, CEO of Navigating Cancer, remarked, "Our platform empowers practices to streamline operations, improve medication adherence, achieve success with value-based reimbursements, and enhance patient experiences through our premier patient portal and the industry's most comprehensive care management resources." This focus on improvement reflects a strong commitment to elevating care quality and operational efficiency.

Looking Forward

The Navigating Cancer platform is already in use by approximately 2,000 providers and serves around one million patients. With the ongoing partnership with OneOncology, significant growth is anticipated as more clinics adopt this platform to improve care delivery.

About OneOncology

Founded by community oncologists, OneOncology is dedicated to improving the quality of life for those affected by cancer. The platform supports community oncology practices in maintaining their independence while ensuring that patients have access to high-quality treatment in their local areas—all while reducing costs compared to hospital-based care. Backed by reputable investors, OneOncology offers its network of community oncology practices essential resources such as group purchasing, operational improvements, practice growth support, and clinical innovation. Currently, the platform includes approximately 1,300 cancer care providers who serve an estimated 787,000 patients across more than 420 care sites. For further information, visit OneOncology's official site.

Frequently Asked Questions

What is Navigating Cancer?

Navigating Cancer is a comprehensive platform for patient engagement and care management specifically designed for oncology, aimed at improving experiences for both providers and patients.

How does OneOncology enhance Navigating Cancer?

OneOncology's acquisition supports Navigating Cancer by enabling significant investments in technology, leading to innovative features and improvements tailored for oncology practices.

What benefits can patients expect from Navigating Cancer?

Patients can look forward to better engagement, improved adherence to medication, and a more streamlined care experience, all designed to promote better health outcomes.

How many providers currently use Navigating Cancer?

Currently, about 2,000 providers utilize the Navigating Cancer platform, serving over one million patients.

What future developments are planned for Navigating Cancer's platform?

Future enhancements include support for bi-specific therapies, improved functionalities for medication adherence, and expanded Chronic Care Management capabilities, all aimed at providing comprehensive patient support.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

LASIK Cost Math Deserves a Careful Second Look Today

Updated Category News Views 114

Thirty years of lens purchases can become a nasty tab Contact-lens spending has a funny way of staying invisible until somebody stacks the receipts into one ugly pile. A new cost-of-vision analysis from the surgeon advisory board of BestLASIKSurgeons.com says the average American contact-lens wearer may spend between $22,500 and $30,000 on corrective eyewear across 30...

Continue Reading
Hexaware’s Seven-Year Client Signal Is Worth Watching

Updated Category News Views 38

Seven straight years of recognition is harder to shrug off than one shiny plaque on a corporate shelf. Hexaware Technologies announced on November 18, 2026 that it received the ISG Star of Excellence Award in the Client Champion category, marking its seventh consecutive year of recognition in that awards program. For investors following IT services, that is a...

Continue Reading
Spruce Spins Adrenyx En Route to Nasdaq in 2027

Updated Category News Views 114

New Frontiers: Adrenyx Biosciences Takes Shape Well, here's a new chapter in biotech drama. Spruce Biosciences, a name you might have tangled with if you're into tickers like NASDAQ:SPRB, just carved out a niche with the birth of Adrenyx Biosciences. The play? A separate company eyeing the endocrinology space, setting its sights on tackling congenital adrenal hyperplasia...

Continue Reading
Vertiv's 800 VDC Push Gives AI Builders More Choices

Updated Category News Views 217

Electricity is becoming the awkward roommate inside every serious AI buildout, and Vertiv is trying to move it out of the rack before it eats the whole house. The company has expanded its 800 VDC offering beyond the PowerDirect 5000 rack product introduced in May 2026, laying out systems for the rack, the AI compute pod, and the full data hall. For investors following...

Continue Reading
Philadelphia Firm Targets 100 Toys for Children This Holiday

Updated Category News Views 157

A hundred unopened toys can look modest on paper, yet that is exactly why this Philadelphia effort lands differently than the usual chest-thumping corporate charity chatter. van der Veen, Hartshorn & Levin has set a clear holiday target: collect 100 new, unwrapped toys for children in the Philadelphia area through the U.S. Marine Corps Reserve Toys for Tots program. No...

Continue Reading
Wonder Create: Democratizing Restaurant Creation

Updated Category News Views 123

Breaking Down Barriers in the Restaurant Industry It's been a long time since someone truly shook up the restaurant scene like this. Wonder Create is stepping in to turn anyone with a wild food idea into a bonafide restaurateur. We're not talking about the ol' franchising route here. We're diving straight into democratizing the culinary world. You seen something this bold...

Continue Reading
Sola's 11-Step Push Makes Salon Ownership Less Blind

Updated Category News Views 141

A pristine studio does not pay rent by itself. That is the uncomfortable little truth sitting underneath Sola Salons’ new 11-step roadmap for beauty professionals considering salon-suite ownership. The company is telling stylists, estheticians, nail technicians, massage therapists, and other independent operators to treat the move from commission work to ownership like...

Continue Reading
Texas Community Bancshares Adds a Special Dividend

Updated Category News Views 109

Nine cents is the whole message—for the moment Texas Community Bancshares has put a little extra cash on the table, declaring a regular quarterly dividend of $0.06 per common share and a special cash dividend of $0.03 per share. Together, holders get $0.09 per share, payable on or about December 15, 2026, provided they are shareholders of record when business closes on...

Continue Reading
Xailient Tops NIST for Real-World AI Face Recognition

Updated Category News Views 87

In a world where bigger ain't always better, Xailient's latest triumph at NIST's face recognition test has set them apart. On November 17, 2026, the U.S. National Institute of Standards and Technology (NIST) crowned Xailient as the leader in face recognition accuracy for on-device AI, leaving 105 others in the dust. This ain't your run-of-the-mill achievement—it shows...

Continue Reading
Hanon's BMW Thermal Win Matters Beyond the Trophy Case Today

Updated Category News Views 32

A 16-Kilogram Box Just Grabbed the Auto Supply Chain’s Attention Hanon Systems did not win these two 2026 PACE honors by polishing up some old hose-and-valve package. Its Highly Integrated Cooling Entity, or HICE, is aimed right at a stubborn electric-vehicle problem: keeping a vehicle’s thermal systems controlled without turning the architecture into a sprawling,...

Continue Reading

Top 5 Most Recently Viewed Articles

Gold's Surge and Euro's Stagnation Amid Economic Shifts

Updated Category News Views 261

Gold Gains Ground Amid Geopolitical Tensions Gold prices have recently shown an impressive rise, climbing 1.9% and breaking through the resistance level of $2,600. This rally followed a significant weekly decline in prices and reflects the market's reaction to ongoing geopolitical uncertainties. The surge in gold can be traced back to several influencing factors. One of...

Continue Reading
Teachable's Innovative Rebrand and Future Learning Vision

Updated Category News Views 209

Teachable's Innovative Rebrand and Future Learning Vision Teachable, a leader in online education, proudly announces a new visual identity and a striking product vision that redefines the learning experience for everyone. As the platform continues to evolve, the changes reflect a deep commitment to meeting the needs of today’s learners and educators. A New Identity for...

Continue Reading
Functionize Elevates Software Testing with Advanced AI Solutions

Updated Category News Views 169

Functionize Enhances Automation for Software Testing Automation Innovations Reshape Testing Using Natural Language Inputs to Create Reliable Tests and Streamline Complex Processes Across Enterprises Functionize, an innovative platform leveraging AI for software test case creation, has unveiled significant enhancements to its intelligent testing solutions. The recent...

Continue Reading
Anterix Inc. Delivers Strong Fiscal Performance This Quarter

Updated Category News Views 199

Anterix Inc. Highlights Its Fiscal Progress Anterix Inc. (NASDAQ: ATEX), based in Woodlang Park, has recently revealed impressive results for its second quarter of fiscal 2026. The company has filed its Form 10-Q, reflecting the financial performance for the three and six months leading to september 30, 2025. During this quarter, Anterix provided an update on its...

Continue Reading
10X Genomics Futures Brighten with New Single Cell Products

Updated Category News Views 80

10X Genomics Holds Steady with New Innovations 10X Genomics (NASDAQ: TXG) has received a reiterated Hold rating from TD Cowen, with a price target set at $20.00. This decision follows the company's announcement of plans to launch new Single Cell (SC) products during an industry event. The innovative products aim to provide cost-effective solutions focused on reducing...

Continue Reading